9AT: VIVO CAPITAL, LLC

other names

VIVO CAPITAL, LLC
VIVO CAPITAL LLC
VIVO VENTURES, LLC

Adviser Profile

As of Date	03/31/2025
ADV Location	PALO ALTO, CA, United States
Adviser Type - Large advisory firm
Number of Employees	67 -8%
of those in investment advisory functions	39 -19%
Registration	SEC, Approved, 06/18/2014
Other registrations (2)	SEC, ERA - Withdrawn, 05/21/2014 California, ERA - Withdrawn, 05/21/2014

AUM^*	5,319,933,012 -8%
of that, discretionary	5,319,933,012 -2%
Private Fund GAV^*	5,624,009,404 0%
Avg Account Size	312,937,236 -13%
SMA’s	No
Private Funds	25 4
Contact Info	650 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Fund Type	Count	GAV
Fund TypePrivate Equity Fund	Count7	GAV$3,638,794,327
Fund TypeVenture Capital Fund	Count9	GAV$698,801,509
Fund TypeOther Private Fund	Count9	GAV$1,286,413,568

Adviser	Hedge Fund	Liquidity Fund	Private Equity Fund	Real Estate Fund	Securitized Asset Fund	Venture Capital Fund	Other Fund	Total Private Fund GAV	AUM	#Funds
Adviser CLOSED LOOP CAPITAL MANAGEMENT	Hedge Fund-	Liquidity Fund-	Private Equity Fund156.1m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund34.7m	Other Fund160.5m	Total Private Fund GAV385.9m	AUM477.1m	#Funds15
Adviser ATHOS PRIVATE WEALTH LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund10.3m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund46.0m	Other Fund6.7m	Total Private Fund GAV108.9m	AUM176.7m	#Funds41
Adviser WESTRIVER MANAGEMENT, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund155.2m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund443.6m	Other Fund122.8m	Total Private Fund GAV1.2b	AUM621.6m	#Funds40
Adviser FOUNDERS CIRCLE CAPITAL, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund208.8m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund883.5m	Other Fund-	Total Private Fund GAV2.0b	AUM1.1b	#Funds33
Adviser BIP CAPITAL	Hedge Fund-	Liquidity Fund-	Private Equity Fund724.4m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund412.7m	Other Fund-	Total Private Fund GAV1.5b	AUM1.1b	#Funds62
Adviser HOF CAPITAL	Hedge Fund-	Liquidity Fund-	Private Equity Fund791.6m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund1.5b	Other Fund-	Total Private Fund GAV3.8b	AUM2.5b	#Funds86
Adviser CARBON DIRECT CAPITAL MANAGEMENT LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund440.1m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund919.6m	Other Fund-	Total Private Fund GAV2.3b	AUM800.0m	#Funds11
Adviser INNOVIUS CAPITAL MANAGEMENT, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund89.0m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund252.8m	Other Fund-	Total Private Fund GAV594.6m	AUM365.5m	#Funds8
Adviser BIP CAPITAL MANAGEMENT SERVICES, LLC	Hedge Fund-	Liquidity Fund-	Private Equity Fund434.4m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund184.0m	Other Fund-	Total Private Fund GAV802.4m	AUM338.0m	#Funds40
Adviser IMPACT ENGINE	Hedge Fund-	Liquidity Fund-	Private Equity Fund270.2m	Real Estate Fund-	Securitized Asset Fund-	Venture Capital Fund42.0m	Other Fund-	Total Private Fund GAV354.3m	AUM256.4m	#Funds8

Stock Ticker	Stock Name	$ Position	% Position	$ Change	# Change
Stck Ticker834203309	Stock NameSoleno Therapeutics Inc	$ Position$154,006,523	% Position12.00%	$ Change-54.00%	# Change-42.00%
Stck Ticker925050106	Stock NameVerona Pharma PLC	$ Position$148,693,129	% Position12.00%	$ Change13.00%	# Change0.00%
Stck Ticker171757206	Stock NameCidara Therapeutics, Inc.	$ Position$125,582,058	% Position10.00%	$ Change97.00%	# Change0.00%
Stck Ticker89532M101	Stock NameTrevi Therapeutics Inc	$ Position$46,616,212	% Position4.00%	$ Change90.00%	# Change14.00%
Stck Ticker880881107	Stock NameTerns Pharmaceuticals Inc	$ Position$51,787,052	% Position4.00%	$ Change101.00%	# Change0.00%
Stck Ticker19240Q201	Stock NameCogent Biosciences Inc	$ Position$40,052,007	% Position3.00%	$ Change397.00%	# Change148.00%
Stck Ticker20454B104	Stock NameCompass Therapeutics Inc	$ Position$33,409,131	% Position3.00%	$ Change113.00%	# Change58.00%
Stck Ticker26818M108	Stock NameDyne Therapeutics Inc	$ Position$33,079,244	% Position3.00%	$ Change212.00%	# Change135.00%
Stck TickerG29687103	Stock NameAvadel Pharmaceuticals PLC	$ Position$40,986,344	% Position3.00%	$ Change73.00%	# Change0.00%
Stck TickerP8696W104	Stock NameSinovac Biotech Ltd.	$ Position$38,192,410	% Position3.00%	$ Change0.00%	# Change0.00%

Brochure Summary

Overview

A. Vivo Capital LLC (“Vivo” or the “Firm”), formerly known as Vivo Ventures, LLC and BioAsia, LLC, is a California limited liability company. Vivo has been in business since 1996 and has been a registered investment adviser since 2014. Vivo serves as an investment adviser to pooled investment vehicles (each, a “Fund” or a “Client” and collectively the “Funds” or “Clients”)1. Vivo’s Funds are reported on Form ADV 1A. An affiliate of Vivo serves as the general partner (or similar managing body) of each Fund. Vivo currently has over 40 investment professionals based both in the U.S. and in Greater China. Vivo’s principal owner is Dr. Frank Kung. B. Vivo is a global healthcare investment firm that focuses on finding and building value in healthcare companies. Vivo invests in both public and private healthcare companies. Vivo is affiliated with entities that serve as the general partners (or similar capacity with regards to entities formed in other jurisdictions) to each of the Funds (each, a “General Partner” and, collectively, the “General Partners”) and each of the Funds is controlled by its respective General Partner. The following is a list of each of the General Partners of the Funds: General Partners:
• Vivo Ventures VII, LLC

• Vivo Ventures Cayman VII (GP), L.P.
• Vivo Capital VIII, LLC
• Vivo Panda, LLC
• Vivo Opportunity, LLC
• Vivo Asia Opportunity, LLC
• Vivo Capital IX, LLC
• Vivo Capital IX (Cayman), LLC
• Vivo Innovation II, LLC
• Vivo Capital X, LLC C. The investment focus and risks of the Funds are more particularly described in each Fund’s offering and governing documents. These guidelines may provide for limits on the size, concentration, geography, type of security and/or terms of the Fund’s investments. The Firm does not tailor its advisory services to individual investors in its Funds. D. The Firm does not participate in wrap fee programs. 1 “Fund” or “Client” means a private investment fund to which Vivo provides investment advice and/or invests on a discretionary basis. The individuals and other persons that invest in the Vivo private investment funds are generally referred to herein as “investors.” Unless otherwise expressly stated herein, the terms “Fund” and “Client” do not include “investors.” E. As of December 31, 2023, Vivo managed $5,809,839,447 in client assets on a discretionary basis. Vivo does not manage any client assets on a non-discretionary basis.

VIVO CAPITAL, LLC

Adviser Profile

Details

Client Types

Advisory Activities

Compensation Arrangments

Reported AUM

Private Funds

Employees

Private Funds Structure

Similar advisers

Top Holdings

Brochure Summary

Overview